JILL HUBER: Open Payments
NPI 1194820829 · NORMAL, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$698 in 31 payments from 16 companies in 2025. Trend: 2023 $176 · 2024 $418 · 2025 $698
Food & beverage: $698
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 5 | $98 |
| AstraZeneca Pharmaceuticals LP | 5 | $95 |
| Viatris Specialty LLC | 3 | $80 |
| JAZZ PHARMACEUTICALS INC. | 2 | $65 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $47 |
| Amgen Inc. | 2 | $44 |
| Axsome Therapeutics, Inc. | 2 | $42 |
| HARMONY BIOSCIENCES LLC | 2 | $37 |
| Avadel CNS Pharmaceuticals, LLC | 1 | $32 |
| Lilly USA, LLC | 1 | $27 |
Products named: YUPELRI, XYWAV, TEZSPIRE, NUCALA, TRELEGY ELLIPTA, Sunosi, FASENRA, WAKIX.
Industry payments across IL — which companies pay providers there.
